Edesa Biotech, Inc.
Markham
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Edesa Biotech, Inc was founded by Stephen Lemieux, Frank Oakes, David Louis Hill, Mayank D. Sampat, Tessie M. Che, Daniel E. Morse, Frank R. Oakes, Mary Catherine Brisson, Gregory T. Baxter, Mark A. McPartland, Kathi Catherine Niffenegger, Kathi Niffenegger, Paul Pay, Jennifer Chao, Lorin Johnson, Michael Brooks, Sean MacDonald, Carlo Sistilli, Pardeep Nijhawan, Patrick Marshall, CHARLES OLSON, David Liu, Joan Chypyha and Peter Weiler, and is based in Markham.
Key facts
- Industry
- Biotechnology
- Legal form
- Incorporated in A1
- Listed
- Nasdaq · EDSA
About
Pharmaceutical Preparations; formerly Stellar Biotechnologies, Inc.; listed on Nasdaq as EDSA; filing with the SEC since 2012
Founders
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
In context
We hold 2,331 other biotechnology companies. None has a closure on record yet. Of the 2,210 that report what they raised, the median is $3,512,633.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment